New potential biomarkers for the study of metabolic dysfunction-associated steatotic liver disease

Congratulations to several of our colleagues on their recent publication investigating the role of neutrophil extracellular traps (NETs) and extracellular DNA (ecDNA) in metabolic dysfunction-associated steatotic liver disease (MASLD). Using different mouse models, the study found that NET formation and ecDNA levels correlate with liver injury severity and fibrosis in severe liver damage models, suggesting they may serve as potential biomarkers for MASLD progression. The research highlights that NET formations and ecDNA levels reflect the extent of liver damage in MASLD.